Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pharmacogenomics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pharmacogenomicsmarket, defines the market attractiveness level of Pharmacogenomics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pharmacogenomics industry, describes the types of Pharmacogenomics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pharmacogenomics market and the development prospects and opportunities of Pharmacogenomics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pharmacogenomics market in Chapter 13.
By Player:
Illumina, Inc
Bayer A
Abbott Laboratories, Inc
Thermo Fisher Scientific Inc
Becton, Dickinson and Company
QIAGEN
Bio-Rad Laboratories, Inc
F Hoffmann-La Roche AG
By Type:
DNA Sequencing
Microarray
Polymerase Chain Reaction
Electrophoresis
Mass Spectrometry
Others
By End-User:
Drug Discovery
Tailored Treatment
Oncology
Pain Management
Other Therapeutic Applications
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pharmacogenomics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pharmacogenomics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pharmacogenomics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pharmacogenomics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pharmacogenomics Market Analysis and Outlook to 2022
-
7.1 Global Pharmacogenomics Consumption (2017-2022)
-
7.2 United States Pharmacogenomics Consumption (2017-2022)
-
7.3 Europe Pharmacogenomics Consumption (2017-2022)
-
7.4 China Pharmacogenomics Consumption (2017-2022)
-
7.5 Japan Pharmacogenomics Consumption (2017-2022)
-
7.6 India Pharmacogenomics Consumption (2017-2022)
-
7.7 South Korea Pharmacogenomics Consumption (2017-2022)
8 Region and Country-wise Pharmacogenomics Market Analysis and Outlook to 2028
-
8.1 Global Pharmacogenomics Consumption Forecast (2022-2028)
-
8.2 United States Pharmacogenomics Consumption Forecast (2022-2028)
-
8.3 Europe Pharmacogenomics Consumption Forecast (2022-2028)
-
8.4 China Pharmacogenomics Consumption Forecast (2022-2028)
-
8.5 Japan Pharmacogenomics Consumption Forecast (2022-2028)
-
8.6 India Pharmacogenomics Consumption Forecast (2022-2028)
-
8.7 South Korea Pharmacogenomics Consumption Forecast (2022-2028)
9 Global Pharmacogenomics Market Outlook by Types and Applications to 2022
-
9.1 Global Pharmacogenomics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global DNA Sequencing Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Microarray Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Polymerase Chain Reaction Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Electrophoresis Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Mass Spectrometry Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Pharmacogenomics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Drug Discovery Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Tailored Treatment Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Pain Management Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Other Therapeutic Applications Consumption and Growth Rate (2017-2022)
10 Global Pharmacogenomics Market Outlook by Types and Applications to 2028
-
10.1 Global Pharmacogenomics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global DNA Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Microarray Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Polymerase Chain Reaction Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Electrophoresis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Mass Spectrometry Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pharmacogenomics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Drug Discovery Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Tailored Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Pain Management Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Other Therapeutic Applications Consumption Forecast and Growth Rate (2022-2028)
11 Global Pharmacogenomics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pharmacogenomics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pharmacogenomics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pharmacogenomics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pharmacogenomics Market Competitive Analysis
-
14.1 Illumina, Inc
-
14.1.1 Illumina, Inc Company Details
-
14.1.2 Illumina, Inc Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Illumina, Inc Pharmacogenomics Product and Service
-
14.2 Bayer A
-
14.2.1 Bayer A Company Details
-
14.2.2 Bayer A Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bayer A Pharmacogenomics Product and Service
-
14.3 Abbott Laboratories, Inc
-
14.3.1 Abbott Laboratories, Inc Company Details
-
14.3.2 Abbott Laboratories, Inc Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Abbott Laboratories, Inc Pharmacogenomics Product and Service
-
14.4 Thermo Fisher Scientific Inc
-
14.4.1 Thermo Fisher Scientific Inc Company Details
-
14.4.2 Thermo Fisher Scientific Inc Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Thermo Fisher Scientific Inc Pharmacogenomics Product and Service
-
14.5 Becton, Dickinson and Company
-
14.5.1 Becton, Dickinson and Company Company Details
-
14.5.2 Becton, Dickinson and Company Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Becton, Dickinson and Company Pharmacogenomics Product and Service
-
14.6 QIAGEN
-
14.6.1 QIAGEN Company Details
-
14.6.2 QIAGEN Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 QIAGEN Pharmacogenomics Product and Service
-
14.7 Bio-Rad Laboratories, Inc
-
14.7.1 Bio-Rad Laboratories, Inc Company Details
-
14.7.2 Bio-Rad Laboratories, Inc Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bio-Rad Laboratories, Inc Pharmacogenomics Product and Service
-
14.8 F Hoffmann-La Roche AG
-
14.8.1 F Hoffmann-La Roche AG Company Details
-
14.8.2 F Hoffmann-La Roche AG Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 F Hoffmann-La Roche AG Pharmacogenomics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pharmacogenomics
-
Figure Pharmacogenomics Picture
-
Table Global Pharmacogenomics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pharmacogenomics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pharmacogenomics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pharmacogenomics Consumption by Country (2017-2022)
-
Figure United States Pharmacogenomics Consumption and Growth Rate (2017-2022)
-
Table Europe Pharmacogenomics Consumption and Growth Rate (2017-2022)
-
Figure China Pharmacogenomics Consumption and Growth Rate (2017-2022)
-
Figure Japan Pharmacogenomics Consumption and Growth Rate (2017-2022)
-
Figure India Pharmacogenomics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pharmacogenomics Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacogenomics Consumption Forecast by Country (2022-2028)
-
Figure United States Pharmacogenomics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pharmacogenomics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pharmacogenomics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pharmacogenomics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pharmacogenomics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pharmacogenomics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DNA Sequencing Consumption and Growth Rate (2017-2022)
-
Figure Global Microarray Consumption and Growth Rate (2017-2022)
-
Figure Global Polymerase Chain Reaction Consumption and Growth Rate (2017-2022)
-
Figure Global Electrophoresis Consumption and Growth Rate (2017-2022)
-
Figure Global Mass Spectrometry Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Discovery Consumption and Growth Rate (2017-2022)
-
Figure Global Tailored Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Pain Management Consumption and Growth Rate (2017-2022)
-
Figure Global Other Therapeutic Applications Consumption and Growth Rate (2017-2022)
-
Figure Global DNA Sequencing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Microarray Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Polymerase Chain Reaction Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Electrophoresis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mass Spectrometry Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Discovery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tailored Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pain Management Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Therapeutic Applications Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pharmacogenomics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pharmacogenomics Export by Region (Top 5 Countries) (2017-2028)
-
Table Illumina, Inc (Foundation Year, Company Profile and etc.)
-
Table Illumina, Inc Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Illumina, Inc Pharmacogenomics Product and Service
-
Table Bayer A (Foundation Year, Company Profile and etc.)
-
Table Bayer A Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer A Pharmacogenomics Product and Service
-
Table Abbott Laboratories, Inc (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories, Inc Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories, Inc Pharmacogenomics Product and Service
-
Table Thermo Fisher Scientific Inc (Foundation Year, Company Profile and etc.)
-
Table Thermo Fisher Scientific Inc Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Inc Pharmacogenomics Product and Service
-
Table Becton, Dickinson and Company (Foundation Year, Company Profile and etc.)
-
Table Becton, Dickinson and Company Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Becton, Dickinson and Company Pharmacogenomics Product and Service
-
Table QIAGEN (Foundation Year, Company Profile and etc.)
-
Table QIAGEN Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
Table QIAGEN Pharmacogenomics Product and Service
-
Table Bio-Rad Laboratories, Inc (Foundation Year, Company Profile and etc.)
-
Table Bio-Rad Laboratories, Inc Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Rad Laboratories, Inc Pharmacogenomics Product and Service
-
Table F Hoffmann-La Roche AG (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche AG Pharmacogenomics Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche AG Pharmacogenomics Product and Service
-
